These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32385059)

  • 21. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
    Sgambatti S; Minamisava R; Bierrenbach AL; Toscano CM; Vieira MA; Policena G; Andrade AL
    Vaccine; 2016 Jan; 34(5):663-670. PubMed ID: 26706272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National, regional, and state-level burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in India: modelled estimates for 2000-15.
    Wahl B; Sharan A; Deloria Knoll M; Kumar R; Liu L; Chu Y; McAllister DA; Nair H; Campbell H; Rudan I; Ram U; Sauer M; Shet A; Black R; Santosham M; O'Brien KL; Arora NK
    Lancet Glob Health; 2019 Jun; 7(6):e735-e747. PubMed ID: 31097277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
    Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
    Vaccine; 2019 May; 37(20):2687-2693. PubMed ID: 30975569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
    Cutts FT; Zaman SM; Enwere G; Jaffar S; Levine OS; Okoko JB; Oluwalana C; Vaughan A; Obaro SK; Leach A; McAdam KP; Biney E; Saaka M; Onwuchekwa U; Yallop F; Pierce NF; Greenwood BM; Adegbola RA;
    Lancet; 2005 Mar 26-Apr 1; 365(9465):1139-46. PubMed ID: 15794968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point-of-care lung ultrasound in children with community acquired pneumonia.
    Yilmaz HL; Özkaya AK; Sarı Gökay S; Tolu Kendir Ö; Şenol H
    Am J Emerg Med; 2017 Jul; 35(7):964-969. PubMed ID: 28202294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.
    Black SB; Shinefield HR; Ling S; Hansen J; Fireman B; Spring D; Noyes J; Lewis E; Ray P; Lee J; Hackell J
    Pediatr Infect Dis J; 2002 Sep; 21(9):810-5. PubMed ID: 12352800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda.
    Gatera M; Uwimana J; Manzi E; Ngabo F; Nwaigwe F; Gessner BD; Moïsi JC
    Vaccine; 2016 Oct; 34(44):5321-5328. PubMed ID: 27639280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiographic findings among children hospitalized with severe community-acquired pneumonia.
    Ferrero F; Nascimento-Carvalho CM; Cardoso MR; Camargos P; March MF; Berezin E; Ruvinsky R; Sant'Anna C; Feris-Iglesias J; Maggi R; Benguigui Y;
    Pediatr Pulmonol; 2010 Oct; 45(10):1009-13. PubMed ID: 20648670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
    Gessner BD; Jiang Q; Van Werkhoven CH; Sings HL; Webber C; Scott D; Gruber WC; Grobbee DE; Bonten MJM; Jodar L
    Vaccine; 2019 Jul; 37(30):4147-4154. PubMed ID: 31155413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan.
    Naito S; Tanaka J; Nagashima K; Chang B; Hishiki H; Takahashi Y; Oikawa J; Nagasawa K; Shimojo N; Ishiwada N
    Epidemiol Infect; 2016 Feb; 144(3):494-506. PubMed ID: 26122538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era: a prospective hospital-based observational study.
    Iroh Tam PY; Chirombo J; Henrion M; Newberry L; Mambule I; Everett D; Mwansambo C; Cunliffe N; French N; Heyderman RS; Bar-Zeev N;
    BMJ Open; 2022 Feb; 12(2):e050188. PubMed ID: 35135765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiographic follow-up of pneumonia in children.
    Virkki R; Juven T; Mertsola J; Ruuskanen O
    Pediatr Pulmonol; 2005 Sep; 40(3):223-7. PubMed ID: 16010671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting community case management of childhood pneumonia: perceptions of caregivers and grass root health providers in Uttar Pradesh and Bihar, northern India.
    Awasthi S; Nichter M; Verma T; Srivastava NM; Agarwal M; Singh JV;
    PLoS One; 2015; 10(4):e0123135. PubMed ID: 25898211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN).
    Lancet; 1999 Apr; 353(9160):1216-21. PubMed ID: 10217081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability and validity of the World Health Organization reading standards for paediatric chest radiographs used in the field in an impact study of Pneumococcal Conjugate Vaccine in Kilifi, Kenya.
    Ominde M; Sande J; Ooko M; Bottomley C; Benamore R; Park K; Ignas J; Maitland K; Bwanaali T; Gleeson F; Scott A
    PLoS One; 2018; 13(7):e0200715. PubMed ID: 30044834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
    Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
    Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis.
    Reyburn R; Tuivaga E; Nguyen CD; Ratu FT; Nand D; Kado J; Tikoduadua L; Jenkins K; de Campo M; Kama M; Devi R; Rafai E; Weinberger DM; Mulholland EK; Russell FM
    Lancet Glob Health; 2021 Jan; 9(1):e91-e98. PubMed ID: 33227258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burden of Severe Pneumonia, Pneumococcal Pneumonia and Pneumonia Deaths in Indian States: Modelling Based Estimates.
    Farooqui H; Jit M; Heymann DL; Zodpey S
    PLoS One; 2015; 10(6):e0129191. PubMed ID: 26086700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.